Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial. // Chinese General Practice Journal. – URL: https://www.sciencedirect.com/science/article/pii/S266637912600529X?dgcid=rss_sd_all
Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial. Chinese General Practice Journal. https://www.sciencedirect.com/science/article/pii/S266637912600529X?dgcid=rss_sd_all
“Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial.” Chinese General Practice Journal.
@article{article4656,
title = {Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial},
journal = {Chinese General Practice Journal},
url = {https://www.sciencedirect.com/science/article/pii/S266637912600529X?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Pierre Garnault, Yannick Aoustin, Vigen Arakelian
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Mihailo Petrovic, Ann-Katrin Stensdotter, Helena Grip
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Michael Croskery, Victor Chan, Ryan B. Graham